| Radiation therapy for solitary plasmacytoma and multiple myeloma: guidelines from the International Lymphoma Radiation Oncology Group RW Tsang, BA Campbell, JS Goda, CR Kelsey, YM Kirova, RR Parikh, ... International Journal of Radiation Oncology* Biology* Physics 101 (4), 794-808, 2018 | 179 | 2018 |
| Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation RR Parikh, BG Haffty, D Lannin, MS Moran International Journal of Radiation Oncology* Biology* Physics 82 (1), 7-13, 2012 | 93 | 2012 |
| Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression RR Parikh, Q Yang, SA Higgins, BG Haffty International Journal of Radiation Oncology* Biology* Physics 70 (1), 35-42, 2008 | 87 | 2008 |
| Evidence-based review on the use of proton therapy in lymphoma from the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee YD Tseng, DJ Cutter, JP Plastaras, RR Parikh, O Cahlon, MD Chuong, ... International Journal of Radiation Oncology* Biology* Physics 99 (4), 825-842, 2017 | 81 | 2017 |
| Local therapy improves overall survival in patients with newly diagnosed metastatic prostate cancer RR Parikh, J Byun, S Goyal, IY Kim The Prostate 77 (6), 559-572, 2017 | 71 | 2017 |
| Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer RR Parikh, D Housman, Q Yang, D Toppmeyer, LD Wilson, BG Haffty International Journal of Radiation Oncology* Biology* Physics 72 (4), 1056-1063, 2008 | 59 | 2008 |
| Prognostic significance of vascular endothelial growth factor protein levels in T1‐2 N0 laryngeal cancer treated with primary radiation therapy RR Parikh, Q Yang, BG Haffty Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 56 | 2007 |
| Prognostic significance of IGF-1R expression in patients treated with breast-conserving surgery and radiation therapy NK Taunk, S Goyal, MS Moran, Q Yang, R Parikh, BG Haffty Radiotherapy and Oncology 96 (2), 204-208, 2010 | 52 | 2010 |
| Patterns of proton therapy use in pediatric cancer management in 2016: an international survey N Journy, DJ Indelicato, DR Withrow, T Akimoto, C Alapetite, M Araya, ... Radiotherapy and Oncology 132, 155-161, 2019 | 51 | 2019 |
| Prevention of N-Methyl-N-Nitrosourea–Induced Breast Cancer by α-Fetoprotein (AFP)–Derived Peptide, a Peptide Derived from the Active Site of AFP RR Parikh, N Gildener-Leapman, A Narendran, HY Lin, N Lemanski, ... Clinical cancer research 11 (23), 8512-8520, 2005 | 50 | 2005 |
| Insurance approval for proton beam therapy and its impact on delays in treatment A Gupta, AJ Khan, S Goyal, R Millevoi, N Elsebai, SK Jabbour, NJ Yue, ... International Journal of Radiation Oncology* Biology* Physics 104 (4), 714-723, 2019 | 49 | 2019 |
| Disparities in survival by insurance status in patients with H odgkin lymphoma RR Parikh, ML Grossbard, BL Green, LB Harrison, J Yahalom Cancer 121 (19), 3515-3524, 2015 | 48 | 2015 |
| Adjuvant proton beam therapy in the management of thymoma: a dosimetric comparison and acute toxicities RR Parikh, R Rhome, E Hug, H Tsai, O Cahlon, B Chon, A Goenka Clinical lung cancer 17 (5), 362-366, 2016 | 41 | 2016 |
| Early-stage classic Hodgkin lymphoma: The utilization of radiation therapy and its impact on overall survival RR Parikh, ML Grossbard, LB Harrison, J Yahalom International Journal of Radiation Oncology* Biology* Physics 93 (3), 684-693, 2015 | 39 | 2015 |
| Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma R Rhome, R Fisher, A Hormigo, RR Parikh Journal of neuro-oncology 128, 241-250, 2016 | 34 | 2016 |
| Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy RR Parikh, BK Moskowitz, E Maher, D Della Rocca, R Della Rocca, ... Leukemia & Lymphoma 56 (5), 1266-1270, 2015 | 33 | 2015 |
| Impact of pathologic lymph node‐positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer A Srivastava, Z Rivera‐Núñez, S Kim, J Sterling, NJ Farber, KD Radadia, ... Cancer 126 (13), 2991-3001, 2020 | 31 | 2020 |
| Association of intensity-modulated radiation therapy on overall survival for patients with Hodgkin lymphoma RR Parikh, ML Grossbard, LB Harrison, J Yahalom Radiotherapy and Oncology 118 (1), 52-59, 2016 | 25 | 2016 |
| BCCIP as a prognostic marker for radiotherapy of laryngeal cancer A Rewari, H Lu, R Parikh, Q Yang, Z Shen, BG Haffty Radiotherapy and Oncology 90 (2), 183-188, 2009 | 24 | 2009 |
| Association of combined modality therapy vs chemotherapy alone with overall survival in early-stage pediatric Hodgkin lymphoma SR Jhawar, Z Rivera-Núñez, R Drachtman, PD Cole, BS Hoppe, ... JAMA oncology 5 (5), 689-695, 2019 | 23 | 2019 |
